Long-Term Study of Nitisinone to Treat Alkaptonuria

NCT00107783 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

NIH

Sponsor class

Conditions

Alkaptonuria

Interventions

DRUG: Nitisinone (NTBC)

Sponsor

National Human Genome Research Institute (NHGRI)